Merck (MRK), Cubist (CBST) Deal Likely to Go Ahead Despite Unfavorable Litigation, Says RBC

Go back to Merck (MRK), Cubist (CBST) Deal Likely to Go Ahead Despite Unfavorable Litigation, Says RBC
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) Delayed: 101.94 --0 (-0%)
Previous Close $101.94    52 Week High $101.99 
Open $3.23    52 Week Low $58.50 
Day High $101.94    P/E N/A 
Day Low $101.94    EPS $-0.27 
Volume 3,714       

Hospira Inc. (NYSE: HSP) Delayed: 89.95 --0 (-0%)
Previous Close $89.95    52 Week High $90.63 
Open $3.49    52 Week Low $46.56 
Day High $89.95    P/E N/A 
Day Low $89.95    EPS $-0.05 
Volume 24,251       

Merck & Co. (NYSE: MRK) Delayed: 135.84 +0.29 (0.21%)
Previous Close $135.55    52 Week High $65.46 
Open $134.43    52 Week Low $47.97 
Day High $135.97    P/E 92.41 
Day Low $133.40    EPS $1.47 
Volume 6,868,318